Lynda Ngozi-Olehi

Lynda Ngozi-Olehi

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 June 2021 in Environmental Analysis Health and Toxicology
Verified
Journal Article
Open access
PDF file
CDChidi Edbert Duru
Chidi Edbert Duru
HUHaruna Isiyaku Umar Umar
Haruna Isiyaku Umar Umar
IDIjeoma Akunna Duru
Ijeoma Akunna Duru
UEUchechi Emmanuela Enenebeaku
Uchechi Emmanuela Enenebeaku
LNLynda Ngozi-Olehi
Lynda Ngozi-Olehi
CEChristian ENYOH
Christian ENYOH
The coronavirus disease of 2019 (COVID-19) has become a global pandemic with rapid rate of transmission and fatalities worldwide. Scientists have been investigating a host of drugs that may be rechanneled to fight this malaise. Thus, in this current computational study we carried out molecular docking experiments to assess the bridging potentials of some commercial drugs such as chloroquine, hydroxychloroquine, lopinavir, ritonavir, nafamostat, camostat, famotidine, umifenovir, nitazoxanide, ivermectin, and fluvoxamine at the interface between human ACE2 and the coronavirus spike glycoprotein complex. This is aimed at ascertaining the ability of these drugs to bridge and prevent the complexing of these two proteins. The crystal structure of human ACE2 and the coronavirus spike glycoprotein complex was retrieved from protein database, while the selected drugs were retrieved from PubChem data base. The proteins and drugs were prepared for docking using Cresset Flare software. The docking was completed via AutoDock Vina module in Python Prescription software. The best hit drugs with each receptor were selected and their molecular interactions were analyzed using BIOVIA’s Discovery Studio 2020. The best hit compounds on the human ACE2 were the lopinavir (-10.1 kcal/mol), ritonavir (-8.9 kcal/mol), and nafamostat (-8.7 kcal/mol). Ivermectin, nafamostat, and camostat with binding energy values -9.0 kcal/mol, -7.8 kcal/mol, and -7.4 kcal/mol respectively were the hit drugs on the coronavirus spike glycoprotein. Nafamostat showed a dual bridging potential against ACE2 and spike glycoprotein, and could therefore be a promising lead compound in the prevention and control of this disease.

13 May 2025 in Physchem
Verified
Journal Article
Open access
PDF file
Kenneth Obichere AmanzeKenneth Obichere Amanze
Kenneth Obichere Amanze
JAJanet O. Amanze
Janet O. Amanze
AEAppolinus I. C. Ehirim
Appolinus I. C. Ehirim
LNLynda Ngozi-Olehi
Lynda Ngozi-Olehi
RURosemary I. Uchegbu
Rosemary I. Uchegbu
CEChristian ENYOH
Christian ENYOH
A 3-Amino-Propyl Trimethoxy Silane (APTS) functionalized silica was prepared and investigated. The functionalized silica showed a powerful removal behavior towards Chromium (III) [Cr (III)] and Cadmium (II) [Cd (II)] ions in aqueous solution. Different factors affecting the heavy metal ions adsorption on these substrates such as pH, initial concentration, contact time, and temperature were investigated. FT-IR analyses were carried out to characterize the functionalization of salicylaldehyde unto 3-aminopropyl silica. Results showed that optimum adsorption of the metal ions occurred at a pH of 7 and 6 by the pure silica and functionalized silica, respectively. Removal efficiencies of the adsorbents showed the trend: Salicylaldehyde-APTS modified > pure silica. The adsorption was described by the Langmuir adsorption isotherm. The kinetic results showed that the adsorption was described well with the pseudo second-order kinetic model. The study reveals that both pure silica and functionalized silica can be used as good adsorbents for the removal of the heavy metal pollutants from aqueous solutions and may be applied in the treatment of industrial waste waters, and they may be useful in detoxifying our already polluted environments.